350 related articles for article (PubMed ID: 22362909)
1. Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy.
Serino G; Sallustio F; Cox SN; Pesce F; Schena FP
J Am Soc Nephrol; 2012 May; 23(5):814-24. PubMed ID: 22362909
[TBL] [Abstract][Full Text] [Related]
2. Interaction between
Wang YN; Zhou XJ; Chen P; Yu GZ; Zhang X; Hou P; Liu LJ; Shi SF; Lv JC; Zhang H
J Am Soc Nephrol; 2021 Mar; 32(3):545-552. PubMed ID: 33593824
[TBL] [Abstract][Full Text] [Related]
3. C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy.
Xing Y; Li L; Zhang Y; Wang F; He D; Liu Y; Jia J; Yan T; Lin S
BMC Nephrol; 2020 Jan; 21(1):18. PubMed ID: 31941451
[TBL] [Abstract][Full Text] [Related]
4. Loss of the Golgi Matrix Protein 130 Cause Aberrant IgA1 Glycosylation in IgA Nephropathy.
Wang C; Ye M; Zhao Q; Xia M; Liu D; He L; Chen G; Peng Y; Liu H
Am J Nephrol; 2019; 49(4):307-316. PubMed ID: 30917363
[TBL] [Abstract][Full Text] [Related]
5. Galactosylation of IgA1 Is Associated with Common Variation in
Gale DP; Molyneux K; Wimbury D; Higgins P; Levine AP; Caplin B; Ferlin A; Yin P; Nelson CP; Stanescu H; Samani NJ; Kleta R; Yu X; Barratt J
J Am Soc Nephrol; 2017 Jul; 28(7):2158-2166. PubMed ID: 28209808
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1 mimics the effect of IL-4 on the glycosylation of IgA1 by downregulating core 1 β1, 3-galactosyltransferase and Cosmc.
Xiao J; Wang M; Xiong D; Wang Y; Li Q; Zhou J; Chen Q
Mol Med Rep; 2017 Feb; 15(2):969-974. PubMed ID: 28035353
[TBL] [Abstract][Full Text] [Related]
7. Activation of the interleukin-4/signal transducer and activator of transcription 6 signaling pathway and homeodomain-interacting protein kinase 2 production by tonsillar mononuclear cells in IgA nephropathy.
He L; Peng Y; Liu H; Yin W; Chen X; Peng X; Shao J; Liu Y; Liu F
Am J Nephrol; 2013; 38(4):321-32. PubMed ID: 24107646
[TBL] [Abstract][Full Text] [Related]
8. [IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].
Xie L; Wang L; Huang J; Fan J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):227-30. PubMed ID: 20337060
[TBL] [Abstract][Full Text] [Related]
9. ST6Gal1 is up-regulated and associated with aberrant IgA1 glycosylation in IgA nephropathy: An integrated analysis of the transcriptome.
Liu Y; Wang F; Zhang Y; Jia J; Yan T
J Cell Mol Med; 2020 Sep; 24(18):10493-10500. PubMed ID: 32677771
[TBL] [Abstract][Full Text] [Related]
10. GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway.
Kiryluk K; Li Y; Moldoveanu Z; Suzuki H; Reily C; Hou P; Xie J; Mladkova N; Prakash S; Fischman C; Shapiro S; LeDesma RA; Bradbury D; Ionita-Laza I; Eitner F; Rauen T; Maillard N; Berthoux F; Floege J; Chen N; Zhang H; Scolari F; Wyatt RJ; Julian BA; Gharavi AG; Novak J
PLoS Genet; 2017 Feb; 13(2):e1006609. PubMed ID: 28187132
[TBL] [Abstract][Full Text] [Related]
11. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.
Suzuki H; Moldoveanu Z; Hall S; Brown R; Vu HL; Novak L; Julian BA; Tomana M; Wyatt RJ; Edberg JC; Alarcón GS; Kimberly RP; Tomino Y; Mestecky J; Novak J
J Clin Invest; 2008 Feb; 118(2):629-39. PubMed ID: 18172551
[TBL] [Abstract][Full Text] [Related]
12. The genetic susceptibility to IgA nephropathy: a novel functional candidate gene for incomplete O-glycosylation of IgA1.
Narita I; Kaneko Y; Kondo D; Goto S; Sakatsume M; Gejyo F
Kidney Int; 2007 Mar; 71(5):379-81. PubMed ID: 17315006
[TBL] [Abstract][Full Text] [Related]
13. The upregulation of miR-98-5p affects the glycosylation of IgA1 through cytokines in IgA nephropathy.
Liu D; Xia M; Liu Y; Tan X; He L; Liu Y; Chen G; Liu H
Int Immunopharmacol; 2020 Feb; 82():106362. PubMed ID: 32126510
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV Inhibits Galactose-Deficient IgA1 Secretion
Liu C; Li X; Shuai L; Dang X; Peng F; Zhao M; Xiong S; Liu Y; He Q
Front Pharmacol; 2021; 12():658236. PubMed ID: 33935780
[No Abstract] [Full Text] [Related]
15. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.
Narita I; Gejyo F
Clin Exp Nephrol; 2008 Oct; 12(5):332-338. PubMed ID: 18404247
[TBL] [Abstract][Full Text] [Related]
16. The Association of rs1047763 and rs1008898 of C1GALT1 with IgA Nephropathy Risk: A Global Meta-Analysis.
Nie R; Cheng G; Zhang J; Dong Y; Wang C; Liu J; Qin X
Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):95-103. PubMed ID: 28636500
[TBL] [Abstract][Full Text] [Related]
17. Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
Suzuki H; Raska M; Yamada K; Moldoveanu Z; Julian BA; Wyatt RJ; Tomino Y; Gharavi AG; Novak J
J Biol Chem; 2014 Feb; 289(8):5330-9. PubMed ID: 24398680
[TBL] [Abstract][Full Text] [Related]
18. Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.
Xie YX; He LY; Chen X; Peng XF; Ye MY; Zhao YJ; Yan WZ; Liu C; Shao J; Peng YM
Int Urol Nephrol; 2016 Nov; 48(11):1855-1861. PubMed ID: 27465795
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
Novak J; Barratt J; Julian BA; Renfrow MB
Semin Nephrol; 2018 Sep; 38(5):461-476. PubMed ID: 30177018
[TBL] [Abstract][Full Text] [Related]
20. Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro.
Lin L; Shen J; Wu X; You Y; Li S
J Vis Exp; 2023 Oct; (200):. PubMed ID: 37902367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
